DOW JONES22,327.48+690.70 3.19%
S&P 5002,626.65+85.18 3.35%
NASDAQ7,774.15+271.77 3.62%

UPDATE: H.C. Wainwright On Taro Pharmaceutical Notes 'At this point, despite Taro's obvious financial strength, we have some misgivings about the company's strategic positioning along with the potential for near- and medium-term revenue growth'

Benzinga · 02/04/2020 17:14